Presented by
Management Forum
Metered Dose Inhaler (MDI) Technology Training Course
A comprehensive overview of MDIs including development, manufacture, regulation and market potential
★★★★★ "I was hoping for further improvement of my understanding of the matter of inhalational drugs, especi... more"
27-30 March 2023
+ 2 more dates
- Format: Live online
- CPD: 12 hours for your records
- Certificate of completion
Course overview
This interactive seminar will provide a comprehensive overview of metered-dose inhaler technology past, present and future, giving participants a valuable insight into market potential and recent industry trends. The programme will clarify the therapeutic targets and look at the various delivery technologies available. There will be detailed coverage of the current environmental, regulatory and economic pressures and how these impact, development, manufacturing process, equipment and options, together with quality and inspection requirements, human factors and bioequivalence. Our highly experienced trainer will address the regulations applying to inhalation products and provide guidance on the regulatory pathways to follow.
The event will benefit those new to this area and will also be of value to anybody who requires a refresher on the opportunities available with this technology. The seminar format will include practical workshops, which past delegates have found invaluable, and ample opportunity for discussion on any specific issues with an expert in this field.
Media Partner
Who should attend?
- Respiratory pharma professionals who need to understand MDI technology and its opportunities
- Medical device professionals new to working in the area of MDIs or those who need a refresher
- Development and regulatory professionals, with a development or product portfolio including MDIs, who need an understanding of future demands
- Medical device business development managers
- Respiratory professionals in R&D
- Medical device manufacturers working in the respiratory market
The Metered Dose Inhaler (MDI) Technology course will cover:
Therapeutic targets
- A brief history of inhalation and MDI therapy
- The lung as a target
- Respiratory diseases
- Systemic delivery
- Therapeutic considerations
- Life limiting Vs Life threatening
Markets past, present and future
- Geographic - Challenges and opportunities
- Disease prevalence
- Economic considerations
- International demand
- Modelling opportunity (what to consider)
Workshop I
- Ranking of competitive technologies for different opportunities
MDI Technology
- How and Why MDIs work
- MDI Formulation approaches
- The elements of an MDI
- Key performance characteristics
- MDI Feature/ Functions compared to other dosage forms
- Add-On technologies for MDIs
- Are there limits to MDI technology?
Regulation of MDIs
- Legislation
- Regulatory guidance
- Consensus standards
- Pharmacopoeial requirements
Workshop II
- SWOT MDI vs multi-dose DPI
- SWOT MDI vs soft mist inhaler
MDI Manufacture
- Key Process steps (space, services, staff)
- Environment (Controls)
- Equipment (Scale, design, options etc.)
- Process controls & Inspection
- Safety and Quality
- Quality by Design (QbD) approaches
- Manufacturing and cost
MDI Testing
- What and when to test
- How to test
- How not to test
- Demonstrating equivalence
Workshop III
- Predictions for inhalation products
- What? When? Why?
Developing an MDI
- The MDI as a drug-device combination product
- Applying Design Controls
- Human Factors & Usability
- Risk management
MDIs and the environment
- Inhaler Carbon Footprint
- Environmental pressures on MDIs
- Alternate propellants (Alternate problems?)
- Alternate design approaches
- Recycling - Technical and patient considerations
The future of the MDI
- Summary of the Course
- What opportunities does the future hold?
- Workshop
David Howlett
Pharma Delivery Solutions
In 2003 David established PharmaDelivery Solutions Ltd as a specialised consultancy service in the field of drug delivery combination products (especially respiratory) device technology. This has led to involvement in projects with focus in pulmonary, nasal and other delivery routes, with an international client base. Much of the activity of PharmaDelivery Solutions Ltd is focused in the area of development programme support, regulatory GAP analysis and generation of documentation supporting development and test programmes, together with data review and contingency evaluation.
David has over 35 years experience in the development, industrialization and approval of inhalation drug delivery systems, combination products and medical devices.
PharmaDelivery Solutions Ltd has provided input ranging from GAP analysis and comment to complete remedial implementation in areas including
• Design Control
• Risk Management
• Materials strategies
• Regulatory documentation
• Technical reviews and opinion
In addition to activities supporting commercial organizations, David has been involved in the following roles;
Honorary Teaching Fellow in the School of Pharmacy and Pharmaceutical Sciences at the University of Manchester and is author/ tutor for the Pharmaceutical Industry Advanced Training (PIAT) MSc module on Inhalation dosage forms.
A UK national expert representing the British Standards Institute on ISO TC84 developing new international standards for pulmonary and nasal delivery devices syringes and catheters.
David has also worked with the United Nations and various national governments to develop and establish transition strategies from the use of CFC in Metered Dose Inhalers and to secure appropriate budgets from the Multi-lateral fun for the implementation of the Montreal Protocol in emerging markets around the world.
Book Metered Dose Inhaler (MDI) Technology Live online training
NEW higher discounts for multiple bookings - bring your colleagues to make your training budget go further:
- 30% off the 2nd delegate*
- 40% off the 3rd delegate*
- 50% off the 4th delegate*
Please contact us for pricing if you are interested in booking 5 or more delegates
27-30 March 2023
Live online
13:30-16:45 UK (London) (UTC+01)
14:30-17:45 Paris (UTC+02)
08:30-11:45 New York (UTC-04)
Course code 12529
- GBP 1,299
- EUR 1,869
- USD 2,129
- 4 sessions of live online training
- Browser-based, no download usually required
- See presenters and interact with fellow attendees
- Download documentation and certification of completion
- Fair transfer and cancellation policy
Not ready to book yet?
for 7 days, no obligation
22-23 June 2023
Live online
09:30-17:15 UK (London) (UTC+01)
10:30-18:15 Paris (UTC+02)
04:30-12:15 New York (UTC-04)
Course code 12211
- GBP 1,099 1,299
- EUR 1,589 1,869
- USD 1,817 2,129
Until 18 May
- 2 days live online training
- Browser-based, no download usually required
- See presenters and interact with fellow attendees
- Download documentation and certification of completion
- Fair transfer and cancellation policy
Not ready to book yet?
for 7 days, no obligation
13-14 September 2023
Live online
09:30-17:15 UK (London) (UTC+01)
10:30-18:15 Paris (UTC+02)
04:30-12:15 New York (UTC-04)
Course code 12307
- GBP 1,099 1,299
- EUR 1,589 1,869
- USD 1,817 2,129
Until 09 Aug
- 2 days live online training
- Browser-based, no download usually required
- See presenters and interact with fellow attendees
- Download documentation and certification of completion
- Fair transfer and cancellation policy
Not ready to book yet?
for 7 days, no obligation
* Early booking discounts may not be combined with other discounts or offers. As such, the discounts for 2nd/3rd/4th delegates are based on the full price.
Reviews of IPI's Metered Dose Inhaler (MDI) Technology training course
I was hoping for further improvement of my understanding of the matter of inhalational drugs, especially MDI, and this expectation was fully met. The speakers had superb knowledge of the subject, vast experience and a great sense of humour.
Sep 18 2019
Robin Boehm 
Team Leader Regulatory Submissions - New Products, STADA Arzneimittel AG
Feb 20 2019
In general good for content and presentation.
Celestino Ronchi 
President, Delim Cosmetics & Pharma s.r.l.
Feb 20 2019
Very good course for those who has no previous experience in this Topic...Thanks to the organisers.
Sami Qassim 
Senior Vice President , Tabuk Pharmaceutical Research Co.
United Kingdom
- 3M
- Avillion LLP
- Chiesi Ltd
- Chiesi SA
- Lupin Healthcare UK
- Medicines and Healthcare Products Regulatory Agency (MHRA)
- MHRA
- Presspart Manufacturing Limited
- Presspart Manufacturing Ltd
- Vectura
Brazil
- Eurofarma Laboratórios SA
- Geolab Pharmaceutical Industry
Germany
- RPC Formatec GmbH
- STADA Arzneimittel AG
Italy
- CHIESI FARMACEUTICI SPA
- Delim Cosmetics & Pharma s.r.l.
Spain
- H&T Presspart
- Presspart
Croatia
- Croatian Agency for Medicinal Products and Medical Devices
Ireland
- Teva Pharmaceuticals Ireland
Jordan
- Tabuk Pharmaceutical Research Co.
United States of America
- Glenmark Pharma
Run Metered Dose Inhaler (MDI) Technology Live online for your team
2 days
Typical duration
Pricing from:
- GBP 800
- Per attendee
- Course tailored to your requirements
- At your choice of location, or online
We can customise this course to your requirements and deliver it on an in-house basis for any number of your staff or colleagues.
Contact our in-house training experts Aleksandra Beer and Yesim Nurko to discuss your requirements:
